Skip to main content

Table 2 Time spent in certain physical activity categories as derived from questionnaires and accelerometry, and physical fitness as determined by cycle ergometry for male and female participants of the study

From: Validation of activity questionnaires in patients with cystic fibrosis by accelerometry and cycle ergometry

Instrument

Variable

Male patients

(n = 18; 4 adults)

Female patients

(n = 23; 7 adults)

Physical activity

7D-PAR

moderate (min/d)

101.1 ± 117.6

114.7 ± 126.1

 

hard (min/d)

48.1 ± 60.8

50.9 ± 68.8

 

very hard (min/d)

38.5 ± 51.8

20.3 ± 26.8

 

Moderate & hard & very hard (min/d)

187.7 ± 193.2

185.8 ± 177.1

 

hard & very hard (min/d)

86.6 ± 102.3

71.2 ± 77.4

HAES

active (min/d)

137.0 ± 132.2

136.5 ± 137.6

 

somewhat active & active (min/d)

358.8 ± 185.6

445.3 ± 202.5

Accelerometry

MPA (min/d)

49.5 ± 17.8

42.1 ± 29.7

 

VPA (min/d)

47.7 ± 24.7

28.6 ± 14.1 **

 

MVPA (min/d)

97.2 ± 36.5

70.8 ± 35.4 *

Physical fitness

Cycle ergometry

Wmax (% predicted)

112.5 ± 22.1

103.5 ± 15.1

 

VO2peak (% predicted)

88.5 ± 16.3

81.0 ± 13.3

  1. Values are mean ± standard deviation.
  2. Abbreviations: 7D-PAR - seven day physical activity recall questionnaire; HAES - habitual activity estimation scale; min/d - minutes per day; MPA - moderate physical activity; VPA - vigorous physical activity; MVPA - moderate and vigorous physical activity; Wmax - maximal power during cycle ergometry; VO2peak - peak oxygen uptake.